NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity

被引:213
作者
Mao, JR [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Pain Ctr, Boston, MA 02114 USA
关键词
NMDA; opioid receptor; interaction;
D O I
10.1016/S0165-0173(99)00020-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Over the last several years, significant progress has been made in our understanding of interactions between the N-methyl-D-aspartate (NMDA) and opioid receptors. Such interactions have been demonstrated at. two distinct sites: (1) modulation of NMDA receptor-mediated electrophysiological events by opioids; and (2) intracellular events involving interactions between NMDA and opioid receptors. Furthermore, a considerable number of studies have shown the involvement of such interactions in neural mechanisms of nociceptive transmission, antinociception in acute and chronic pain states, opioid tolerance/dependence, and neuroplasticity. Importantly, emerging evidence indicates that activation of NMDA receptors may differentially modulate functions mediated by distinct opioid receptor subtypes, namely mu, delta, and kappa receptors. These studies have greatly enriched our knowledge regarding both NMDA and opioid receptor systems and have shed light on neurobiology of both acute and chronic pain. The advancement of such knowledge also promotes new strategies for better clinical management of pain patients. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:289 / 304
页数:16
相关论文
共 140 条
[1]  
Aley KO, 1997, J NEUROSCI, V17, P3907
[2]   REGULATION OF HERMISSENDA K+ CHANNELS BY CYTOPLASMIC AND MEMBRANE-ASSOCIATED C-KINASE [J].
ALKON, DL ;
NAITO, S ;
KUBOTA, M ;
CHEN, C ;
BANK, B ;
SMALLWOOD, J ;
GALLANT, P ;
RASMUSSEN, H .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (03) :903-917
[3]   THE KAPPA-OPIOID RECEPTOR IS PRIMARILY POSTSYNAPTIC - COMBINED IMMUNOHISTOCHEMICAL LOCALIZATION OF THE RECEPTOR AND ENDOGENOUS OPIOIDS [J].
ARVIDSSON, U ;
RIEDL, M ;
CHAKRABARTI, S ;
VULCHANOVA, L ;
LEE, JH ;
NAKANO, AH ;
LIN, XQ ;
LOH, HH ;
LAW, PY ;
WESSENDORF, MW ;
ELDE, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :5062-5066
[4]  
ARVIDSSON U, 1995, J NEUROSCI, V15, P3328
[5]  
ARVIDSSON U, 1995, J NEUROSCI, V15, P1215
[6]   BEHAVIORAL EVIDENCE THAT SYSTEMIC MORPHINE MAY MODULATE A PHASIC PAIN-RELATED BEHAVIOR IN A RAT MODEL OF PERIPHERAL MONONEUROPATHY [J].
ATTAL, N ;
CHEN, YL ;
KAYSER, V ;
GUILBAUD, G .
PAIN, 1991, 47 (01) :65-70
[7]   PHARMACOLOGY OF MORPHINE AND MORPHINE-3-GLUCURONIDE AT OPIOID, EXCITATORY AMINO-ACID, GABA AND GLYCINE BINDING-SITES [J].
BARTLETT, SE ;
DODD, PR ;
SMITH, MT .
PHARMACOLOGY & TOXICOLOGY, 1994, 75 (02) :73-81
[8]   IMMUNOCYTOCHEMICAL LOCALIZATION OF DELTA-OPIOID RECEPTORS IN MOUSE-BRAIN [J].
BAUSCH, SB ;
PATTERSON, TA ;
APPLEYARD, SM ;
CHAVKIN, C .
JOURNAL OF CHEMICAL NEUROANATOMY, 1995, 8 (03) :175-189
[9]  
BEN ES, 1992, BRAIN RES, V575, P304
[10]  
BENNETT GJ, 1989, NATO ADV SCI I A-LIF, V176, P463